Chair of the Board · Immunovant, Inc. (IMVT)

Frank M. Torti, M.D director compensation at Immunovan (FY2026): $4.1M

Fiscal year 2026 director compensation for Frank M. Torti, M.D at Immunovant, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed July 22, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Frank M. Torti, M.D’s full pay file as a PDF — free

More than this page: up to 10 years of Frank’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Frank M. Torti, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Immunovant Director Compensation Table · all 3 fiscal years held
In US dollars, as Immunovant reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2026$92,500$3,030,348$971,380$0$4,094,228
FY2025$92,500$3,705,912$1,134,978$0$4,933,390
FY2024$92,500$1,792,165$1,809,832—$3,694,497

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immunovant, Inc. DEF 14A filed July 22, 2026, accession 0001764013-26-000092, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Immunovant, Inc. filed document, accession 0001764013-26-000092. Every figure is read from that document and cited to the page and table it appears in. Filed July 22, 2026.

Get the Immunovant Board Governance Report

$4,094,228 Frank M. Torti, M.D, FY2026 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of July 22, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2026

Immunovant pays directors a $50,000 cash retainer and $425,000 in 75% RSU / 25% Option.

Committees

FY2026 · as the proxy prints them

Compensation

The rest of the Immunovant board

FY2026 · as the company reported each
DirectorRoleFY2026 total
Andrew FromkinIndependent Director$397,351
Atul Pande, M.DIndependent Director$384,850
Douglas HughesIndependent Director$392,117
Eric Venker, M.D., Pharm.DDirector$2,597
Jacob BauerIndependent Director$862,075
Robert SusmanIndependent Director$854,926

The full Immunovant compensation record

free company brief

This page is one director within Immunovant's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Immunovant proxy · each links to its own free brief

Order IMVT

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report